Update from the National Hypertension Taskforce of Australia: prevalence, treatment and control rates of hypertension between 2022 and 2024 - implications and future directions.
Amelie H Ohlrogge, Xiaoyue Xu, Andrew Goodman, Garry Jennings, Lisa Murphy, Mark R Nelson, James E Sharman, Rob Tassie, Markus P Schlaich, Aletta E Schutte
{"title":"Update from the National Hypertension Taskforce of Australia: prevalence, treatment and control rates of hypertension between 2022 and 2024 - implications and future directions.","authors":"Amelie H Ohlrogge, Xiaoyue Xu, Andrew Goodman, Garry Jennings, Lisa Murphy, Mark R Nelson, James E Sharman, Rob Tassie, Markus P Schlaich, Aletta E Schutte","doi":"10.1097/HJH.0000000000004358","DOIUrl":null,"url":null,"abstract":"<p><p>High blood pressure is the dominant risk factor for cardiovascular diseases and death in Australia. The blood pressure control rate in Australia was reported at 32% based on 2017-2018 data, which is substantially lower than other high-income countries. New results from the National Health Survey show an improvement of the crude control rate to 39.6% in the years 2022-2023, though changes in methodology need to be considered in the interpretation. Hypertension prevalence has increased from 33.7 to 39.4%. The prevalence and control rates vary strongly across diverse population groups. The age-standardized prevalence among First Nations peoples is higher than in the general population (37.8 versus 35%), and age-standardized blood pressure control rates are lower (22.2 versus 31.1%). Younger individuals and those in socioeconomically disadvantaged areas have substantially lower control rates, highlighting the need for greater equity to achieve the National Hypertension Taskforce's goal of 70% blood pressure control by 2030.</p>","PeriodicalId":16043,"journal":{"name":"Journal of Hypertension","volume":" ","pages":"1457-1461"},"PeriodicalIF":5.6000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13336605/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HJH.0000000000004358","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/5/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
High blood pressure is the dominant risk factor for cardiovascular diseases and death in Australia. The blood pressure control rate in Australia was reported at 32% based on 2017-2018 data, which is substantially lower than other high-income countries. New results from the National Health Survey show an improvement of the crude control rate to 39.6% in the years 2022-2023, though changes in methodology need to be considered in the interpretation. Hypertension prevalence has increased from 33.7 to 39.4%. The prevalence and control rates vary strongly across diverse population groups. The age-standardized prevalence among First Nations peoples is higher than in the general population (37.8 versus 35%), and age-standardized blood pressure control rates are lower (22.2 versus 31.1%). Younger individuals and those in socioeconomically disadvantaged areas have substantially lower control rates, highlighting the need for greater equity to achieve the National Hypertension Taskforce's goal of 70% blood pressure control by 2030.
期刊介绍:
The Journal of Hypertension publishes papers reporting original clinical and experimental research which are of a high standard and which contribute to the advancement of knowledge in the field of hypertension. The Journal publishes full papers, reviews or editorials (normally by invitation), and correspondence.